Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates

Additional Metadata
Keywords	drug-eluting stent(s), dualantiplatelet therapy, high bleeding risk, high thrombotic risk, zotarolimus-eluting stent(s)
Persistent URL	doi.org/10.1016/j.jacc.2014.11.053, hdl.handle.net/1765/85158
Journal	Journal of the American College of Cardiology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Valgimigli, M., Patialiakas, A., Thury, A., McFadden, E., Colangelo, S., Campo, G., Tebaldi, M., Ungi, I., Tondi, S., Roffi, M., Menozzi, A., de Cesare, N., Garbo, R., Meliga, E., Testa, L., Gabriel, H., Airoldi, F., Ferlini, M., Liistro, F., … Briguori, C. (2015). Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. Journal of the American College of Cardiology, 65(8), 805–815.https://doi.org/10.1016/j.jacc.2014.11.053

Publication